Novel YAP1/TAZ pathway inhibitors identified through phenotypic screening with potent anti-tumor activity via blockade of GGTase-I / Rho-GTPase signaling
K. Graham, P. Lienau, B. Bader, S. Prechtl, J. Naujoks, R. Lesche, J. Weiske, J. Kuehnlenz, K. Brzezinka, L. Potze, F. Zanconato, B. Nicke, A. Montebaur, W. Bone, S. Golfier, , M. Lange
bioRxiv · Aug 30, 2023 · PreprintCancer Biology